Taro Pharmaceutical Indus...

NYSE: TARO · Real-Time Price · USD
42.98
0.01 (0.02%)
At close: Jun 21, 2024, 9:59 PM

Taro Pharmaceutical Industries Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Net Income
53.87M 25.45M 58.27M -400.74M
Depreciation & Amortization
31.09M 32.13M 25.91M 23.68M
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
15.73M -60.12M -268.6M 433.89M
Other Non-Cash Items
34.27M -4.72M 12.96M 584K
Deferred Income Tax
19.15M 16.8M 23.2M -38.41M
Change in Working Capital
28.1M -37.91M -279.04M 460.66M
Operating Cash Flow
132.39M 31.75M -158.7M 45.77M
Capital Expenditures
-54.22M -17.85M -12.04M -17.14M
Cash Acquisitions
n/a -1.98M -91.87M 161K
Purchase of Investments
-1.5M -107.71M -66.67M -1.13B
Sales Maturities Of Investments
140.06M 866.45M 809.12M 1.22B
Other Investing Acitivies
138.31M -864.47M -809.12M -161K
Investing Cash Flow
84.34M -125.56M -170.58M 67.74M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -24.93M -24.2M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -24.93M -24.2M
Financial Cash Flow
n/a n/a -24.93M -24.2M
Net Cash Flow
208.41M -96.64M -354.04M 91.82M
Free Cash Flow
78.17M 13.9M -170.74M 28.63M